Edwards Lifesciences Corp (EW)
95.15
+1.73
(+1.85%)
USD |
NYSE |
Mar 27, 16:00
95.20
+0.05
(+0.05%)
Pre-Market: 08:48
Edwards Lifesciences Enterprise Value: 56.24B for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | 56.24B |
March 26, 2024 | 55.20B |
March 25, 2024 | 55.04B |
March 22, 2024 | 55.42B |
March 21, 2024 | 55.95B |
March 20, 2024 | 54.97B |
March 19, 2024 | 55.73B |
March 18, 2024 | 54.85B |
March 15, 2024 | 54.53B |
March 14, 2024 | 55.16B |
March 13, 2024 | 54.90B |
March 12, 2024 | 53.69B |
March 11, 2024 | 53.64B |
March 08, 2024 | 54.43B |
March 07, 2024 | 55.43B |
March 06, 2024 | 52.13B |
March 05, 2024 | 50.79B |
March 04, 2024 | 51.35B |
March 01, 2024 | 50.26B |
February 29, 2024 | 50.05B |
February 28, 2024 | 50.73B |
February 27, 2024 | 51.04B |
February 26, 2024 | 50.82B |
February 23, 2024 | 51.78B |
February 22, 2024 | 51.71B |
Date | Value |
---|---|
February 21, 2024 | 51.12B |
February 20, 2024 | 51.27B |
February 16, 2024 | 50.79B |
February 15, 2024 | 50.76B |
February 14, 2024 | 50.76B |
February 13, 2024 | 50.89B |
February 12, 2024 | 51.41B |
February 09, 2024 | 50.14B |
February 08, 2024 | 50.61B |
February 07, 2024 | 51.10B |
February 06, 2024 | 52.09B |
February 05, 2024 | 50.77B |
February 02, 2024 | 50.79B |
February 01, 2024 | 46.35B |
January 31, 2024 | 46.21B |
January 30, 2024 | 43.44B |
January 29, 2024 | 43.85B |
January 26, 2024 | 43.05B |
January 25, 2024 | 43.23B |
January 24, 2024 | 42.63B |
January 23, 2024 | 44.00B |
January 22, 2024 | 44.20B |
January 19, 2024 | 43.69B |
January 18, 2024 | 43.77B |
January 17, 2024 | 43.40B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
31.68B
Minimum
Mar 23 2020
80.39B
Maximum
Dec 30 2021
52.12B
Average
49.91B
Median
Enterprise Value Benchmarks
Stryker Corp | 146.35B |
Boston Scientific Corp | 109.15B |
Align Technology Inc | 23.67B |
Zimmer Biomet Holdings Inc | 32.70B |
Becton Dickinson & Co | 86.15B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 369.90M |
Revenue (Quarterly) | 1.534B |
Total Expenses (Quarterly) | 1.106B |
EPS Diluted (Quarterly) | 0.61 |
Gross Profit Margin (Quarterly) | 76.74% |
Profit Margin (Quarterly) | 24.11% |
Earnings Yield | 2.42% |
Operating Earnings Yield | 2.98% |
Normalized Earnings Yield | 2.694 |